Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Screening method of single memory b cells and its application in the preparation of small molecule monoclonal antibodies

A monoclonal antibody, chloramphenicol technology, applied in the field of cell biology and immunology, can solve the problems of easy volatilization and degradation, insufficient reverse transcription, low-efficiency amplification, etc., to achieve high affinity, high practical value, The effect of overcoming technical barriers

Active Publication Date: 2022-03-29
CHINA AGRI UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antibody preparation of traditional single B cells requires artificial single-cell RNA extraction and transcript amplification, but the amount of single-cell RNA is small, volatile and degradable, and has strict environmental requirements, and has undergone insufficient reverse transcription and low After efficient amplification, some important transcripts will be lost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Screening method of single memory b cells and its application in the preparation of small molecule monoclonal antibodies
  • Screening method of single memory b cells and its application in the preparation of small molecule monoclonal antibodies
  • Screening method of single memory b cells and its application in the preparation of small molecule monoclonal antibodies

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0050]The preparation method of chloramphenicol immunogen CAP-KLH is as follows: 1 mg CAP-HS is dissolved in 500 μL DMF, 2.75 mg NHS is dissolved in 200 μL DMF, and 2.75 mg EDC is dissolved in 400 μL DMF. 500 μL of the reaction solution was slowly added dropwise to 2 mg of KLH, and the reaction was shaken at 4°C overnight. Another 500 μL of the reaction solution was added with 2 mg BSA, and dialyzed for 72 h. The solution obtained from coupling was aliquoted and stored at -20°C ( figure 1 ).

[0051] The immunological formulation was prepared as follows: CAP-KLH (at a concentration of 4 mg / mL) was mixed with complete Freund's adjuvant / incomplete Freund's adjuvant in equal volumes and emulsified.

[0052] The immunization method is as follows: multi-point injection immunization method on the neck and back. The number of immunizations was 8. The first immunization was the primary immunization with complete Freund's adjuvant, and the other immunizations were performed with inc...

Embodiment 1

[0064] Example 1 Immunization of New Zealand White Rabbit

[0065] The concentration of the immunogen (CAP-KLH) was adjusted to 4 mg / mL with PBS buffer, and the concentration of the immunogen was determined by the Bicinchoninic Acid method.

[0066] Take 6 New Zealand white rabbits (2 months old, weight 2.5kg), numbered CAP-KLH-1, CAP-KLH-2, CAP-KLH-3, CAP-KLH-4, CAP-KLH-5 and CAP -KLH-6. New Zealand white rabbits were immunized eight times, and the immunization method was 4-8 points on the back of the neck.

[0067] The first immunization: each animal was immunized with 1 mL of the first-immune preparation (each 1 mL of the first-immune preparation contained 1 mg of CAP-KLH).

[0068] The second to eighth immunizations: counting the days from the first immunization, one immunization every 30 days for a total of 7 booster immunizations; the first 3 boosters, each immunized with 1mg CAP-KLH; the last 3 boosters Immunization, 800μg, 600μg and 400μg, respectively. One week aft...

Embodiment 2

[0069] Example 2 Affinity identification of New Zealand white rabbit antiserum

[0070] Antisera obtained one week after immunization were tested for titer and sensitivity. The assay method is indirect ELISA. The specific operation steps are as follows:

[0071] The coated original CAP-BSA was diluted with carbonate buffer (pH 9.6) to 0.1 μg / mL, coated with 100 μL / well of ELISA plate, incubated at 37°C for 2 h, and then washed three times with PBST solution. The ELISA plate was then blocked with 2% nonfat dry milk (150 μL / well), incubated at 37° C. for 1 h, washed three times with PBST solution, and patted dry. The antiserum was serially diluted with PBS, starting from a 1:4000 dilution, with a 2-fold gradient, and a total of 8 dilutions. Add 50 μL of PBS buffer and 50 μL of serially diluted antiserum solution to the coated ELISA plate, incubate at 37°C for 30 min, then wash with PBST solution for 3 times and pat dry. 100 μL of enzyme-labeled secondary antibody diluent (ho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for screening single memory B cells and its application in the preparation of small molecule monoclonal antibodies. Based on flow sorting technology and microfluidic technology, the present invention realizes the organic combination of precise screening of antigen-specific memory B cells and efficient preparation of single-cell transcripts in a microenvironment, and further performs single-cell variable region pre-amplification , prokaryotic expression of scFv and eukaryotic expression of monoclonal antibody. Establish a new type of monoclonal antibody preparation technology to provide a new method for the preparation of small molecule rabbit monoclonal antibodies.

Description

technical field [0001] The present invention relates to the field of cell biology and immunology, in particular to a method for screening single memory B cells and its application in the preparation of small molecule monoclonal antibodies. Background technique [0002] Rabbit-derived monoclonal antibodies have been widely used in biology, medicine, environmental testing and food science due to their advantages of high specificity, high activity, high affinity and recognition of more novel epitopes. With the development of monoclonal antibody technology, Epitomics Company of the United States has prepared rabbit myeloma cells, and successfully obtained rabbit monoclonal antibodies through hybridoma technology, but the instability of rabbit myeloma cell lines makes this technology unable to be widely promoted use. [0003] Recombinant rabbit monoclonal antibodies have the advantages of high consistency and repeatability while maintaining the advantages of the above rabbit mon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0781C12N15/10C07K16/44C07K16/06G01N33/577G01N33/53
CPCC12N5/0635C12N15/1096C07K16/44C07K16/06G01N33/577G01N33/5308C12N2509/00C07K2317/56C07K2317/92C07K2317/622C07K2317/94C12Q2531/113
Inventor 王战辉沈建忠温凯余文博于雪芝江海洋李园李培培
Owner CHINA AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products